2026
Reconfiguration of certain derivatives operations at the Mizushima Works to strengthen profitability by FY 2030
May 12, 2026
Reconfiguration of certain derivatives operations at the Mizushima Works to strengthen profitability by FY 2030
Medium-term management plan for 2027 “Trailblaze Together”
April 15, 2026
Medium-term management plan for 2027 “Trailblaze Together”
2025
Briefing on Acquisition of Aicuris Anti-infective Cures AG
February 26, 2026
Expansion of our antiviral pipeline in the critical infection space—overview of the strategic rationale.
First Priority Business Briefing
January 8, 2026
Strategies for the four priority growth businesses under the Mid-Term Plan 2027 presented by segment leaders.
Medium-term management plan for 2027 “Trailblaze Together”
April 10, 2025
Medium-term management plan for 2027 “Trailblaze Together”
2024
Intangible Assets Briefing
December 13, 2024
How human capital, IP, technology, and digital assets drive competitive advantage, and the business models centered on them.
Asahi Kasei to Acquire Calliditas Therapeutics AB
May 28, 2024
Strategy to expand the U.S. pharmaceutical business into renal disease, including details of the acquisition.
Medium-term management plan 2024
May 20, 2024
Medium-term management plan 2024
Separator Business Briefing
April 25, 2024
Overview of the decision to build an integrated separator production facility in Ontario, Canada, for Hipore™.
2023
Material Sector Business Briefing
December 21, 2023
Future vision and strategies for materials businesses, including digital solutions and hydrogen, amid petrochemical restructuring.
Medium-term management plan 2024
April 11, 2023
Medium-term management plan 2024
DX Strategy Briefing
December 7, 2023
Progress in digital transformation and examples of business innovation to accelerate structural reform and growth.
Separator Business Briefing
March 8, 2023
Transition from integrated to independent operations of Hipore™ and Polypore—strategic overview.
2022
Analyst Meeting on Sustainability
January 20, 2023
Initiatives under “Green” and “People” to achieve a virtuous cycle of social contribution and corporate value growth.
DX Strategy Briefing
December 13, 2022
Overview of initiatives related to digital transformation (DX), one of the key themes of the Mid-Term Management Plan.
Critical Care Business Briefing
November 16, 2022
Latest updates on ZOLL and long-term growth strategy, including the impact of the pandemic.
IP Strategy Briefing
July 7, 2022
Role of IP Intelligence and integration of IP and business strategies to drive management and business strategy.
Medium-term management plan 2024
April 11, 2022
Medium-term management plan 2024
2021
Homes Business Briefing
December 9, 2021
Current status and mid- to long-term strategy of the homes business, with a focus on profitability and customer satisfaction.
Analyst Meeting on Sustainability
November 29, 2021
Update on the group’s sustainability initiatives and progress from the previous year.
Health Care Sector Business Briefing
October 5, 2021
Strategy to become a global healthcare company leveraging diverse growth drivers across pharma and medical businesses.
Medium-term management initiative "Cs+ for Tomorrow 2021"
May 25, 2021
Medium-term management initiative "Cs+ for Tomorrow 2021"
